These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 19948974)

  • 1. Reduction of circulating soluble fms-like tyrosine kinase-1 plays a significant role in renal dysfunction-associated aggravation of atherosclerosis.
    Onoue K; Uemura S; Takeda Y; Somekawa S; Iwama H; Imagawa K; Nishida T; Morikawa Y; Takemoto Y; Asai O; Soeda T; Okayama S; Ishigami K; Nakatani K; Kawata H; Horii M; Nakajima T; Akai Y; Iwano M; Saito Y
    Circulation; 2009 Dec; 120(24):2470-7. PubMed ID: 19948974
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Suppressed soluble Fms-like tyrosine kinase-1 production aggravates atherosclerosis in chronic kidney disease.
    Matsui M; Takeda Y; Uemura S; Matsumoto T; Seno A; Onoue K; Tsushima H; Morimoto K; Soeda T; Okayama S; Somekawa S; Samejima K; Kawata H; Kawakami R; Nakatani K; Iwano M; Saito Y
    Kidney Int; 2014 Feb; 85(2):393-403. PubMed ID: 24048373
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Suppressed Production of Soluble Fms-Like Tyrosine Kinase-1 Contributes to Myocardial Remodeling and Heart Failure.
    Seno A; Takeda Y; Matsui M; Okuda A; Nakano T; Nakada Y; Kumazawa T; Nakagawa H; Nishida T; Onoue K; Somekawa S; Watanabe M; Kawata H; Kawakami R; Okura H; Uemura S; Saito Y
    Hypertension; 2016 Sep; 68(3):678-87. PubMed ID: 27480835
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Elevated Soluble Fms-Like Tyrosine Kinase-1 and Placental-Like Growth Factor Levels Are Associated With Development and Mortality Risk in Heart Failure.
    Hammadah M; Georgiopoulou VV; Kalogeropoulos AP; Weber M; Wang X; Samara MA; Wu Y; Butler J; Tang WH
    Circ Heart Fail; 2016 Jan; 9(1):e002115. PubMed ID: 26699385
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An elevated ratio of placental growth factor to soluble fms-like tyrosine kinase-1 predicts adverse outcomes in patients with stable coronary artery disease.
    Matsumoto T; Uemura S; Takeda Y; Matsui M; Okada S; Nishida T; Soeda T; Okayama S; Somekawa S; Ishigami K; Onoue K; Kawata H; Kawakami R; Horii M; Saito Y
    Intern Med; 2013; 52(10):1019-27. PubMed ID: 23676585
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of the PlGF/Flt-1 signaling pathway in the cardiorenal connection.
    Saito Y
    J Mol Cell Cardiol; 2021 Feb; 151():106-112. PubMed ID: 33045252
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Letter by Di Marco and Brand regarding article, "Reduction of circulating soluble fms-like tyrosine kinase-1 plays a significant role in renal dysfunction-associated aggravation of atherosclerosis".
    Di Marco GS; Brand M
    Circulation; 2010 Aug; 122(5):e416; athor reply e417. PubMed ID: 20679579
    [No Abstract]   [Full Text] [Related]  

  • 8. Increased soluble fms-like tyrosine kinase 1 after ischemia reperfusion contributes to adverse clinical outcomes following kidney transplantation.
    Wewers TM; Mayer AB; Pfleiderer A; Beul K; Schmidt R; Heitplatz B; Van Marck V; Nolte I; Pavenstädt H; Reuter S; Brand M; Di Marco GS
    Kidney Int; 2019 May; 95(5):1091-1102. PubMed ID: 30824181
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Circulating Soluble Fms-like Tyrosine Kinase in Renal Diseases Other than Preeclampsia.
    Wewers TM; Schulz A; Nolte I; Pavenstädt H; Brand M; Di Marco GS
    J Am Soc Nephrol; 2021 Aug; 32(8):1853-1863. PubMed ID: 34155060
    [TBL] [Abstract][Full Text] [Related]  

  • 10. AST-120, an Oral Carbon Absorbent, Protects against the Progression of Atherosclerosis in a Mouse Chronic Renal Failure Model by Preserving sFlt-1 Expression Levels.
    Nakada Y; Onoue K; Nakano T; Ishihara S; Kumazawa T; Nakagawa H; Ueda T; Nishida T; Soeda T; Okayama S; Watanabe M; Kawakami R; Saito Y
    Sci Rep; 2019 Oct; 9(1):15571. PubMed ID: 31666542
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Soluble fms-Like Tyrosine Kinase 1 as a Link Between Angiogenesis and Endothelial Dysfunction in Pediatric Patients With β-Thalassemia Intermedia.
    Tantawy AAG; Adly AAM; Ismail EAR; Youssef OI; Ali ME
    Clin Appl Thromb Hemost; 2017 Nov; 23(8):943-950. PubMed ID: 28301910
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Maternal serum placental growth factor and soluble fms-like tyrosine kinase 1 as early predictors of preeclampsia.
    Shokry M; Bedaiwy MA; Fathalla MM; Alsemary A; Elwakil S; Murphy A
    Acta Obstet Gynecol Scand; 2010; 89(1):143-6. PubMed ID: 20021269
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Usefulness of soluble Fms-like tyrosine kinase-1 as a biomarker of acute severe heart failure in patients with acute myocardial infarction.
    Onoue K; Uemura S; Takeda Y; Somekawa S; Iwama H; Nishida T; Morikawa Y; Nakagawa H; Tsutsumi T; Sung JH; Takemoto Y; Soeda T; Okayama S; Ishigami K; Kawata H; Horii M; Nakajima T; Saito Y
    Am J Cardiol; 2009 Dec; 104(11):1478-83. PubMed ID: 19932778
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Soluble fms-like tyrosine kinase-1 and atherosclerosis in chronic kidney disease.
    Luft FC
    Kidney Int; 2014 Feb; 85(2):238-40. PubMed ID: 24487364
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The sFlt-1/PlGF ratio in different types of hypertensive pregnancy disorders and its prognostic potential in preeclamptic patients.
    Verlohren S; Herraiz I; Lapaire O; Schlembach D; Moertl M; Zeisler H; Calda P; Holzgreve W; Galindo A; Engels T; Denk B; Stepan H
    Am J Obstet Gynecol; 2012 Jan; 206(1):58.e1-8. PubMed ID: 22000672
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel marker for the detection of sickle cell nephropathy: soluble FMS-like tyrosine kinase-1 (sFLT-1).
    Youssry I; Makar S; Fawzy R; Wilson M; AbdAllah G; Fathy E; Sawires H
    Pediatr Nephrol; 2015 Dec; 30(12):2163-8. PubMed ID: 26238275
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Soluble Fms-like tyrosine kinase 1 is a novel predictor of brain natriuretic peptide elevation.
    Kameda R; Yamaoka-Tojo M; Makino A; Wakaume K; Nemoto S; Kitasato L; Shimohama T; Tojo T; Machida Y; Izumi T
    Int Heart J; 2013; 54(3):133-9. PubMed ID: 23774235
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New gestational phase-specific cutoff values for the use of the soluble fms-like tyrosine kinase-1/placental growth factor ratio as a diagnostic test for preeclampsia.
    Verlohren S; Herraiz I; Lapaire O; Schlembach D; Zeisler H; Calda P; Sabria J; Markfeld-Erol F; Galindo A; Schoofs K; Denk B; Stepan H
    Hypertension; 2014 Feb; 63(2):346-52. PubMed ID: 24166751
    [TBL] [Abstract][Full Text] [Related]  

  • 19. sFlt-1 in Chronic Kidney Disease: Friend or Foe?
    Matsui M; Onoue K; Saito Y
    Int J Mol Sci; 2022 Nov; 23(22):. PubMed ID: 36430665
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Urinary angiogenic factors cluster hypertensive disorders and identify women with severe preeclampsia.
    Buhimschi CS; Norwitz ER; Funai E; Richman S; Guller S; Lockwood CJ; Buhimschi IA
    Am J Obstet Gynecol; 2005 Mar; 192(3):734-41. PubMed ID: 15746665
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.